PositiveID and GenArraytion Partner on Firefly Dx
August 04, 2015 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Aug. 04, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, and...
PositiveID Corporation Receives Nucleic Acids From the CDC Influenza Division to Develop a Diagnostic Assay to Detect H5N1 Avian Flu
March 28, 2012 08:29 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., March 28, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes...
PositiveID Corporation Announces Second Quarter 2011 Accomplishments and Mid-Year Update
August 23, 2011 08:00 ET
|
PositiveID Corporation
Mid-year highlights include the submission of iglucose 510(k) to the FDA and U.S. Department of Homeland Security validation of the Company's recently launched multiplex biothreat assay
Additional...
U.S. Department of Homeland Security Validates Performance of PositiveID Corporation's Multiplex BioThreat Assay Through an In-House Blind Study
August 11, 2011 08:00 ET
|
PositiveID Corporation
DHS' Science and Technologies Division Confirms Performance of the PSIDMBA
New Website Available at www.psidmba.com
DELRAY BEACH, Fla., Aug. 11, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation...
PositiveID Corporation Announces the Launch of its Multiplex BioThreat Assay, the First Commercially Available Product of its Kind
June 21, 2011 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., June 21, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical...